XML 15 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net (Loss) $ (14,030,277) $ (126,361)
Adjustments to reconcile net loss to net cash used in operating activities    
Loss on conversion of related party debt into common stock 10,604,620
Loss on conversion of trade payables into common stock 993,715
Loss on conversion of Series A preferred stock into common stock 1,735,500
Gain on settlement of accounts payable for Series B preferred stock (211,600)
Issuance of Series B preferred stock for consulting services 566,000
Depreciation and amortization 509
Provision for excess inventory 2,225
Change in fair value of warrant liabilities 278,630 (101,993)
Change in fair value of derivative liabilities 21,143 (3,549)
Changes in operating assets and liabilities    
Inventory 135
Prepaid expenses and other current assets 6,773 8,194
Accounts payable (218,327) (7,578)
Accrued expenses 61,446 (193,604)
Accounts payable - related party (198,040) 150,000
Accrued expenses - related party 207,754 119,659
Net cash (used in) operating activities (180,438) (154,588)
Cash flows from investing activities    
Net cash from investing activities
Cash flows from financing activities    
Proceeds from issuance of notes payable to related parties 220,000 250,000
Repayment of convertible notes payable (50,000)
Net cash provided by financing activities 220,000 200,000
Net increase (decrease) in cash 39,562 45,412
Cash, beginning of year 7,402 6,701
Cash, end of year 46,964 52,113
Cash paid during the year for:    
Interest 7,627
Income taxes
Non-cash financing activities:    
Conversion of related party debt and accrued interest into common stock 2,012,447
Settlement of restated party debt and accrued interest into common stock version of related party debt and accrued interest into common stock 2,848,078
Conversion of related party amounts payable into common stock 381,155
Conversion of series A preferred stock into common stock 75,000
Conversion of related party and other amounts payable into series B preferred stock 461,867
Settlement of derivative liability due to conversion $ 8,624